Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesA Case of Progressive Hypertension Preceding Gemcitabine-Associated Thrombotic Microangiopathy Complicated by Acute Kidney Injury and Stroke
Renal Failure, 10/29/09
Phelan PJ et al. – The authors report a normotensive patient who developed progressive hypertension after commencing gemcitabine therapy. She also developed subtle changes in her platelet count and serum creatinine months before her emergent presentation. Clinicians should be aware of new onset or worsening hypertension and 'mild' biochemical changes in gemcitabine–treated patients.
Related Articles
Injury time - losing out in acute kidney injury
British Journal of Renal Medicine, 10/26/09
Relevance Score: 70%
The effects of vasopressin on acute kidney injury in septic shock
Intensive Care Medicine, 10/29/09
Relevance Score: 68%
Accuracy of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Diagnosis and Prognosis in Acute Kidney Injury: A Systematic Review and Meta-analysis
American Journal of Kidney Diseases, 10/28/09
Relevance Score: 68%
Activated Protein C and Acute Kidney Injury: Selective Targeting of PAR-1
Current Drug Targets, 11/03/09
Relevance Score: 67%
Cause of Death in Multiorgan Donors and Its Relation to the Function of Transplanted Kidneys
Transplantation Proceedings, 11/10/09
Relevance Score: 66%
Today in Nephrology...keeping you current
Receive free subspecialty "5-minute updates" via email
Vasculitis
Journal of Allergy and Clinical Immunology, 12/04/09
Does endothelin B receptor deficiency ameliorate the induction of peritoneal fibrosis in experimental peritoneal dialysis
Nephrology Dialysis Transplantation, 12/04/09
External Validation of the Mayo Clinic Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear-Cell Renal Cell Carcinoma in a Single European Centre Applying Routine Pathology
European Urology, 12/04/09
Sponsor
Article Search
Sponsor